Ensuring Accurate and Complete Abortion Data Reporting Act of 2019

COVID response (general); Hyde Amendment; House Amendment to Senate Amendment to H.R. 925 HEROES Act; S. 178 UIGHUR Act of 2019; S. 4320 Coronavirus Response Additional Supplemental Appropriations Act; S.3072 Support and Value Moms and Babies Act; H.R. 7608 State and Foreign Operations Appropriations; H.R. 7617 Labor, Health and Human Services Appropriations; Maternal mortality; Abortion in tax code; S. 2585, H.R. 3580 Ensuring Accurate and Complete Abortion Data Reporting; H.R. 8353/S.4658 Womens Public Health and Safety Act; S. 3310 Womens Global Empowerment, Development and Prosperity Act; Chemical abortion; Defunding abortion providers; Bioethics; H.R. 2010 Second Chance at Life Act; H.R. 6742/S. 4658 Protecting Life in Crisis Act; H.R. 4934 Dignity for Aborted Children; Supreme Court nomination of Amy Coney Barrett; H.Res. 1153 Condemning unwanted, unnecessary medical procedures for individuals without their full, informed consent; H.R. 573 Protecting Life and Integrity in Research Act; S. 514 Deborah Sampson Act; H.R. 6395/S. 4049 NDAA 2021; H.R. 4995 Maternal Health Quality Improvement Act; Consolidated Appropriations Act.

Client expense: $160,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Abortion-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page. Contacts in support of the Pain-Capable Unborn Child Protection Act (S. 160/H.R. 784), to protect pain-capable unborn children beginning at 20 weeks fetal age. Contacts in support of the Save Our Children Act of 2019 (H.R. 956) to ban dismemberment abortions and the Dismemberment Abortion Ban Act (S. 1035), to prohibit a physician from knowingly performing a dismemberment abortion. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 962/S. 311/S.130), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a urging signing of a discharge petition. Letter sent to the House dated February 28, 2020 on a Motion to Recommit. Letter sent to the Senate dated Febuary 21, 2020. Contacts in support of administrative action enforcing existing EMTALA provisions regarding infact treatment and the Born-Alive Infant protection act to the fullest extent possible by law. Contacts in support of the No Taxpayer Funding for Abortion Act (S.109/H.R. 20) to codify government-wide policy against funding abortion. Contacts in support of the Conscience Protection Act (H.R. 2014/S.183), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts regarding legislation to defund certain abortion providers (S. 141/H.R. 369/S.1966/H.R.833) to prohibit federal funding to entities that do not certify the entities will not perform, or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Consultations regarding letters of inquiry regarding whether abortion providers have violated various provisions of law regarding human fetal tissue sale or the partial birth abortion ban law. Contacts regarding a resolution condemning unwanted, unnecessary medical procedures on individuals without their full, informed consent (H. Res. 1154). No position taken. Contacts in support of legislation (not introduced) banning unwanted medical procedures. Contacts regarding the Pregnant Workers Fairness Act (H.R. 2694). No position taken. Contacts regarding legislation to improve abortion reporting (S.2585/H.R.3580 and others not introduced). Contacts in response to inquiries regarding the Heartbeat Bill (H.R. 490) and similar legislation not introduced to prohibit abortions if a fetal heartbeat is detectable; no position taken this quarter. Contacts in opposition to "EACH Woman Act" (H.R. 1692/S. 758), a bill to mandate coverage of abortion without limitation in Medicaid, Medicare, CHIP, and other federally funded health insurance program, to nullify the laws in effect in about half of the states that restrict coverage of abortion in health plans sold on the Obamacare exchanges, and to nullify all other state laws or policies that "inhibit insurance coverage of abortion by private health plans." Contacts in support of the Second Chance at Life Act (H.R. 2010) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of agency action limiting the use of tissue from aborted babies to the extent permitted by law. Contacts in support of Title X regulations to bar grantees from co-locating with abortion clinics or referring clients for abortions. Contacts in support of legislation dealing with the disposal of fetal remains (H.R. 4934/ H.R. 671/S.2590). Contacts in support of agency action strengthening regulation surrounding the use of mifepristone and RU-486 to the extent permitted by law. Additional urging to enforce REMS during Covid-19 pandemic. Contacts in support of the Down Syndrome Discrimination by Abortion Prohibition Act (S.2754/ H.R.4903 ) to prohibit abortions on the basis that the unborn child has or may have Down syndrome. Contacts in support of the Support And Value Expectant (SAVE) Moms and Babies Act of 2019 (S.3072 /H.R. 4399) to prevent labeling changes for already approved abortion drugs; prevents providers from dispensing these abortion drugs remotely, by mail, or via telemedicine; and prevent the Food and Drug Administration (FDA) from approving new chemical abortion drugs. Contacts regarding the Parental Accessibility Rights for Emergency and Negligent Treatment Act (S.3138) to require any healthcare facility that receives Medicaid or CHIP funds to make public their policies related to the provision, withdrawal, or denial of life-sustaining procedures, nutrition, or medication, policies related to parental consent of these services, and policies related to the required notification of parents and parental consent for a do-not-resuscitate order. Contacts in support of the Teleabortion Prevention Act of 2019 (H.R.4935) to prohibit abortionists from performing chemical abortions without being physically present. Contacts regarding the Parental Right to Know Act (S.3137) to require any healthcare facility that receives Medicaid or CHIP funds to include the information on parental access to medical records of minors under the age of 18 on their website and in print, upon request of the patient or parent. Contacts explaining nonsupport for the Life at Conception Act (S.159/H.R. 616) and the Sanctity of Human Life Act (H.R. 305) based on lack of clarity and erroneous legal premises. Contacts urging HHS to prioritize stem cell research that has the best chance of producing near-term benefits in treatments for patients, without the creation, destruction, or risk of injury to human embryos. Contacts in support of the Womens Right to Know Act (H.R. 6077/S. 3388) to give women truthful, non-misleading information prior to an abortion. Contacts in support of enforcement of numerous federal statues as they relate to the conscience protection rights of those not willing to participate in, refer, or pay for abortion. Contacts in opposition to the HEROES Act 2.0, which contains numerous provisions that permit funds to flow to the abortion industry as well as potentially funneling millions of dollars into programs without Hyde protections. Contacts in support of H.R. 6742, the Protecting Life in Crisis Act which would extend existing Hyde Amendment protections to any COVID-19-related healthcare provisions.

COVID response (general); Hyde Amendment;S. 3072 Support and Value Moms and Babies Act; Defunding abortion providers. S. 2585, H.R. 3580 Ensuring Accurate and Complete Abortion Data Reporting; H.R. 8353, S.4658 Womens Public Health and Safety Act;

Client expense: $200,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

COVID response (general); Providing treatment for infants; Hyde Amendment; House Amendment to Senate Amendment to H.R. 925 HEROES Act; S. 178 UIGHUR Act of 2019; S. 4320 Coronavirus Response Additional Supplemental Appropriations Act; S.3072 Support and Value Moms and Babies Act; H.R. 7608 State and Foreign Operations Appropriations; H.R. 7617 Labor, Health and Human Services Appropriations; Maternal mortality; Abortion in tax code; S. 2585, H.R. 3580 Ensuring Accurate and Complete Abortion Data Reporting; S. 3608 Coronavirus Relief Fund Flexibility for State and Local Government Act; H.R. 8353, S.4658 Womens Public Health and Safety Act; H.R. 7718 Protecting the Health and Wellness of Babies and Pregnant Women in Custody Act; H.R. 2694 Pregnant Workers Fairness Act; S. 4003 Keeping Women and Girls Safe from the Start; S. 3310 Womens Global Empowerment, Development and Prosperity Act; Chemical abortion; Defunding abortion providers; Bioethics.

Client expense: $200,000 · Firm income: Not reported

For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Abortion-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page. Contacts in support of the Pain-Capable Unborn Child Protection Act (S. 160/H.R. 784), to protect pain-capable unborn children beginning at 20 weeks fetal age including a letter to the Senate dated February 21, 2020. Contacts in support of the Save Our Children Act of 2019 (H.R. 956) to ban dismemberment abortions and the Dismemberment Abortion Ban Act (S. 1035), to prohibit a physician from knowingly performing a dismemberment abortion. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 962/S. 311/S.130), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a urging signing of a discharge petition. Letter sent to the House dated February 28, 2020 on a Motion to Recommit. Letter sent to the Senate dated Febuary 21, 2020. Contacts in support of administrative action enforcing existing EMTALA provisions regarding infact treatment and the Born-Alive Infant protection act to the fullest extent possible by law. Contacts in support of the No Taxpayer Funding for Abortion Act (S.109/H.R. 20) to codify government-wide policy against funding abortion. Contacts in support of the Conscience Protection Act (H.R. 2014/S.183), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts regarding legislation to defund certain abortion providers (S. 141/H.R. 369/S.1966/H.R.833) to prohibit federal funding to entities that do not certify the entities will not perform, or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Consultations regarding letters of inquiry regarding whether abortion providers have violated various provisions of law regarding human fetal tissue sale or the partial birth abortion ban law. Contacts regarding a resolution condemning unwanted, unnecessary medical procedures on individuals without their full, informed consent (H. Res. 1154). No position taken. Contacts in support of legislation (not introduced) banning unwanted medical procedures. Contacts regarding the Pregnant Workers Fairness Act (H.R. 2694). No position taken. Contacts regarding legislation to improve abortion reporting (S.2585/H.R.3580 and others not introduced). Contacts in response to inquiries regarding the Heartbeat Bill (H.R. 490) and similar legislation not introduced to prohibit abortions if a fetal heartbeat is detectable; no position taken this quarter. Contacts in opposition to "EACH Woman Act" (H.R. 1692/S. 758), a bill to mandate coverage of abortion without limitation in Medicaid, Medicare, CHIP, and other federally funded health insurance program, to nullify the laws in effect in about half of the states that restrict coverage of abortion in health plans sold on the Obamacare exchanges, and to nullify all other state laws or policies that "inhibit insurance coverage of abortion by private health plans." Contacts in support of the Second Chance at Life Act (H.R. 2010) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of agency action limiting the use of tissue from aborted babies to the extent permitted by law. Contacts in support of Title X regulations to bar grantees from co-locating with abortion clinics or referring clients for abortions. Contacts in support of legislation dealing with the disposal of fetal remains (H.R. 4934/ H.R. 671/S.2590). Contacts in support of agency action strengthening regulation surrounding the use of mifepristone and RU-486 to the extent permitted by law. Additional urging to enforce REMS during Covid-19 pandemic. Contacts in support of the Down Syndrome Discrimination by Abortion Prohibition Act (S.2754/ H.R.4903 ) to prohibit abortions on the basis that the unborn child has or may have Down syndrome. Contacts in support of the Support And Value Expectant (SAVE) Moms and Babies Act of 2019 (S.3072 /H.R. 4399) to prevent labeling changes for already approved abortion drugs; prevents providers from dispensing these abortion drugs remotely, by mail, or via telemedicine; and prevent the Food and Drug Administration (FDA) from approving new chemical abortion drugs. Contacts regarding the Parental Accessibility Rights for Emergency and Negligent Treatment Act (S.3138) to require any healthcare facility that receives Medicaid or CHIP funds to make public their policies related to the provision, withdrawal, or denial of life-sustaining procedures, nutrition, or medication, policies related to parental consent of these services, and policies related to the required notification of parents and parental consent for a do-not-resuscitate order. Contacts in support of the Teleabortion Prevention Act of 2019 (H.R.4935) to prohibit abortionists from performing chemical abortions without being physically present. Contacts regarding the Parental Right to Know Act (S.3137) to require any healthcare facility that receives Medicaid or CHIP funds to include the information on parental access to medical records of minors under the age of 18 on their website and in print, upon request of the patient or parent. Contacts explaining nonsupport for the Life at Conception Act (S.159/H.R. 616) and the Sanctity of Human Life Act (H.R. 305) based on lack of clarity and erroneous legal premises. Contacts urging HHS to prioritize stem cell research that has the best chance of producing near-term benefits in treatments for patients, without the creation, destruction, or risk of injury to human embryos. Contacts in support of the Womens Right to Know Act (H.R. 6077/S. 3388) to give women truthful, non-misleading information prior to an abortion. Contacts in support of enforcement of numerous federal statues as they relate to the conscience protection rights of those not willing to participate in, refer, or pay for abortion. Contacts in opposition to the HEROES Act 2.0, which contains numerous provisions that permit funds to flow to the abortion industry as well as potentially funneling millions of dollars into programs without Hyde protections. Contacts in support of H.R. 6742, the Protecting Life in Crisis Act which would extend existing Hyde Amendment protections to any COVID-19-related healthcare provisions.

For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Abortion-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page. Contacts in support of the Pain-Capable Unborn Child Protection Act (S. 160/H.R. 784), to protect pain-capable unborn children beginning at 20 weeks fetal age including a letter to the Senate dated February 21, 2020. Contacts in support of the Save Our Children Act of 2019 (H.R. 956) to ban dismemberment abortions and the Dismemberment Abortion Ban Act (S. 1035), to prohibit a physician from knowingly performing a dismemberment abortion. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 962/S. 311/S.130), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a urging signing of a discharge petition. Letter sent to the House dated February 28, 2020 on a Motion to Recommit. Letter sent to the Senate dated Febuary 21, 2020. Contacts in support of the No Taxpayer Funding for Abortion Act (S.109/H.R. 20) to codify government-wide policy against funding abortion. Contacts in support of the Conscience Protection Act (H.R. 2014/S.183), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts regarding legislation to defund certain abortion providers (S. 141/H.R. 369/S.1966/H.R.833) to prohibit federal funding to entities that do not certify the entities will not perform, or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (S.2585/H.R.3580 and others not introduced). Contacts in response to inquiries regarding the Heartbeat Bill (H.R. 490) and similar legislation not introduced to prohibit abortions if a fetal heartbeat is detectable; no position taken this quarter. Contacts in opposition to "EACH Woman Act" (H.R. 1692/S. 758), a bill to mandate coverage of abortion without limitation in Medicaid, Medicare, CHIP, and other federally funded health insurance program, to nullify the laws in effect in about half of the states that restrict coverage of abortion in health plans sold on the Obamacare exchanges, and to nullify all other state laws or policies that "inhibit insurance coverage of abortion by private health plans." Contacts in support of the Second Chance at Life Act (H.R. 2010) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of agency action limiting the use of tissue from aborted babies to the extent permitted by law. Contacts in support of Title X regulations to bar grantees from co-locating with abortion clinics or referring clients for abortions. Contacts in support of legislation dealing with the disposal of fetal remains (H.R. 4934/ H.R. 671/S.2590). Contacts in support of agency action strengthening regulation surrounding the use of mifepristone and RU-486 to the extent permitted by law. Additional urging to enforce REMS during Covid-19 pandemic. Contacts in support of the Down Syndrome Discrimination by Abortion Prohibition Act (S.2754/ H.R.4903 ) to prohibit abortions on the basis that the unborn child has or may have Down syndrome. Contacts in support of the Support And Value Expectant (SAVE) Moms and Babies Act of 2019 (S.3072 /H.R. 4399) to prevent labeling changes for already approved abortion drugs; prevents providers from dispensing these abortion drugs remotely, by mail, or via telemedicine; and prevent the Food and Drug Administration (FDA) from approving new chemical abortion drugs. Contacts regarding the Parental Accessibility Rights for Emergency and Negligent Treatment Act (S.3138) to require any healthcare facility that receives Medicaid or CHIP funds to make public their policies related to the provision, withdrawal, or denial of life-sustaining procedures, nutrition, or medication, policies related to parental consent of these services, and policies related to the required notification of parents and parental consent for a do-not-resuscitate order. Contacts in support of the Teleabortion Prevention Act of 2019 (H.R.4935) to prohibit abortionists from performing chemical abortions without being physically present. Contacts regarding the Parental Right to Know Act (S.3137) to require any healthcare facility that receives Medicaid or CHIP funds to include the information on parental access to medical records of minors under the age of 18 on their website and in print, upon request of the patient or parent. Contacts explaining nonsupport for the Life at Conception Act (S.159/H.R. 616) and the Sanctity of Human Life Act (H.R. 305) based on lack of clarity and erroneous legal premises. Contacts urging HHS to prioritize stem cell research that has the best chance of producing near-term benefits in treatments for patients, without the creation, destruction, or risk of injury to human embryos. Contacts in support of the Womens Right to Know Act (H.R. 6077/S. 3388) to give women truthful, non-misleading information prior to an abortion. Contacts in support of enforcement of numerous federal statues as they relate to the conscience protection rights of those not willing to participate in, refer, or pay for abortion. Contacts in opposition to H.R. 6800 (HEROS Act), which contains numerous provisions aimed at propping up the abortion industry as well as potentially funneling millions of dollars into programs without Hyde protections; letter to the House dated May 15, 2020. Contacts in support of H.R. 6742, the Protecting Life in Crisis Act which would extend existing Hyde Amendment protections to any COVID-19-related healthcare provisions.

For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Abortion-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page. Contacts in support of the Pain-Capable Unborn Child Protection Act (S. 160/H.R. 784), to protect pain-capable unborn children beginning at 20 weeks fetal age including a letter to the Senate dated February 21, 2020. Contacts in support of the Save Our Children Act of 2019 (H.R. 956) to ban dismemberment abortions and the Dismemberment Abortion Ban Act (S. 1035), to prohibit a physician from knowingly performing a dismemberment abortion. Contacts in support of the Prenatal Nondiscrimination Act or PRENDA (S. 182/ H.R.2373 ) to prohibit discrimination against the unborn on the basis of sex. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 962/S. 311/S.130), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a urging signing of a discharge petition. Letter sent to the House dated February 28, 2020 on a Motion to Recommit. Letter sent to the Senate dated Febuary 21, 2020. Contacts in support of the No Taxpayer Funding for Abortion Act (S.109/H.R. 20) to codify government-wide policy against funding abortion. Contacts in support of Child Interstate Abortion Notification Act (CIANA)(S. 119/ H.R.611), to require an abortionist to notify a parent before performing an abortion on a minor from a different state, with certain exceptions. Contacts in support of Child Custody Protection Act S.194/ H.R.2817), to prohibit transporting a minor across a state line to obtain an abortion without satisfying a parental involvement law in the minor's resident state. Contacts in support of the Conscience Protection Act (H.R. 2014/S.183), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts regarding legislation to defund certain abortion providers (S. 141/H.R. 369/S.1966/H.R.833) to prohibit federal funding to entities that do not certify the entities will not perform, or provide any funding to any other entity that performs, an abortion, with certain exceptions. Contacts in support of the Title X Abortion Provider Prohibition Act (S. 105/H.R. 296) to make abortion providers ineligible to receive Title X family planning funds. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (S.2585/H.R.3580 and others not introduced). Contacts in response to inquiries regarding the Heartbeat Bill (H.R. 490) and similar legislation not introduced to prohibit abortions if a fetal heartbeat is detectable; no position taken this quarter. Contacts in opposition to "EACH Woman Act" (H.R. 1692/S. 758), a bill to mandate coverage of abortion without limitation in Medicaid, Medicare, CHIP, and other federally funded health insurance program, to nullify the laws in effect in about half of the states that restrict coverage of abortion in health plans sold on the Obamacare exchanges, and to nullify all other state laws or policies that "inhibit insurance coverage of abortion by private health plans." Contacts in support of the Second Chance at Life Act (H.R. 2010) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Responses to inquiries regarding the Ultrasound Informed Consent Act (H.R. 634), which provides that prior to an abortion, a provider must perform an obstetric ultrasound on the pregnant woman; provide a simultaneous explanation of what the ultrasound is depicting and display the ultrasound images so that the pregnant woman may view them. Contacts in support of agency action limiting the use of tissue from aborted babies to the extent permitted by law. Contacts in support of Title X regulations to bar grantees from co-locating with abortion clinics or referring clients for abortions. Contacts in support of legislation dealing with the disposal of fetal remains (H.R. 4934/ H.R. 671/S.2590). Contacts in support of agency action strengthening regulation surrounding the use of mifepristone and RU-486 to the extent permitted by law. Additional urging to not roll back REMS during Covid-19 pandemic. Contacts in support of the Down Syndrome Discrimination by Abortion Prohibition Act (S.2754/ H.R.4903 ) to prohibit abortions on the basis that the unborn child has or may have Down syndrome. Contacts in support of the Support And Value Expectant (SAVE) Moms and Babies Act of 2019 (S.3072 /H.R. 4399) to prevent labeling changes for already approved abortion drugs; prevents providers from dispensing these abortion drugs remotely, by mail, or via telemedicine; and prevent the Food and Drug Administration (FDA) from approving new chemical abortion drugs. Contacts regarding the Parental Accessibility Rights for Emergency and Negligent Treatment Act (S.3138) to require any healthcare facility that receives Medicaid or CHIP funds to make public their policies related to the provision, withdrawal, or denial of life-sustaining procedures, nutrition, or medication, policies related to parental consent of these services, and policies related to the required notification of parents and parental consent for a do-not-resuscitate order. Contacts in support of the Teleabortion Prevention Act of 2019 (H.R.4935) to prohibit abortionists from performing chemical abortions without being physically present. Contacts regarding the Parental Right to Know Act (S.3137) to require any healthcare facility that receives Medicaid or CHIP funds to include the information on parental access to medical records of minors under the age of 18 on their website and in print, upon request of the patient or parent. Contacts explaining nonsupport for the Life at Conception Act (S.159/H.R. 616) and the Sanctity of Human Life Act (H.R. 305) based on lack of clarity and erroneous legal premises. Contacts urging HHS to prioritize stem cell research that has the best chance of producing near-term benefits in treatments for patients, without the creation, destruction, or risk of injury to human embryos. Contacts in support of the Womens Right to Know Act (H.R. 6077/S. 3388) to give women truthful, non-misleading information prior to an abortion. Contacts in support of enforcement of numerous federal statues as they relate to the conscience protection rights of those not willing to participate in, refer, or pay for abortion.

Issues Surrounding Criminal Justice Reform Issues related to the First Step Act Implementation and CJS Appropriations (S. 2585) Issues related to H.R. 1076, S. 387 (Fair Chance Act) and the National Defense Authorization Act (NDAA) S. 1074: Pell Grants for Incarcerated individuals H.R. 5065: Prison to Proprietorship for Formerly Incarcerated Act H.R. 5078: Prison to Proprietorship Act

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Abortion-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page. Contacts in support of the Pain-Capable Unborn Child Protection Act (S. 160/H.R. 784), to protect pain-capable unborn children beginning at 20 weeks fetal age. Contacts in support of the Save Our Children Act of 2019 (H.R. 956) to ban dismemberment abortions and the Dismemberment Abortion Ban Act (S. 1035), to prohibit a physician from knowingly performing a dismemberment abortion. Contacts in support of the Prenatal Nondiscrimination Act or PRENDA (S. 182/ H.R.2373 ) to prohibit discrimination against the unborn on the basis of sex. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 962/S. 311/S.130), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a urging signing of a discharge petition. Contacts in support of the No Taxpayer Funding for Abortion Act (S.109/H.R. 20) to codify government-wide policy against funding abortion. Contacts in support of Child Interstate Abortion Notification Act (CIANA)(S. 119/ H.R.611), to require an abortionist to notify a parent before performing an abortion on a minor from a different state, with certain exceptions. Contacts in support of Child Custody Protection Act S.194/ H.R.2817), to prohibit transporting a minor across a state line to obtain an abortion without satisfying a parental involvement law in the minor's resident state. Contacts in support of the Conscience Protection Act (H.R. 2014/S.183), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts regarding legislation to defund certain abortion providers (S. 141/H.R. 369/S.1966/H.R.833) to prohibit federal funding to entities that do not certify the entities will not perform, or provide any funding to any other entity that performs, an abortion, with certain exceptions. Contacts in support of the Title X Abortion Provider Prohibition Act (S. 105/H.R. 296) to make abortion providers ineligible to receive Title X family planning funds. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (S.2585/H.R.3580 and others not introduced). Contacts in response to inquiries regarding the Heartbeat Bill (H.R. 490) and similar legislation not introduced to prohibit abortions if a fetal heartbeat is detectable; no position taken this quarter. Contacts in opposition to "EACH Woman Act" (H.R. 1692/S. 758), a bill to mandate coverage of abortion without limitation in Medicaid, Medicare, CHIP, and other federally funded health insurance program, to nullify the laws in effect in about half of the states that restrict coverage of abortion in health plans sold on the Obamacare exchanges, and to nullify all other state laws or policies that "inhibit insurance coverage of abortion by private health plans." Contacts in support of the Second Chance at Life Act (H.R. 2010) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Responses to inquiries regarding the Ultrasound Informed Consent Act (H.R. 634), which provides that prior to an abortion, a provider must perform an obstetric ultrasound on the pregnant woman; provide a simultaneous explanation of what the ultrasound is depicting and display the ultrasound images so that the pregnant woman may view them. Contacts in support of agency action limiting the use of tissue from aborted babies to the extent permitted by law. Contacts in support of Title X regulations to bar grantees from co-locating with abortion clinics or referring clients for abortions. Contacts in support of legislation dealing with the disposal of fetal remains (H.R. 4934/ H.R. 671/S.2590). Contacts in support of agency action strengthening regulation surrounding the use of mifepristone and RU-486 to the extent permitted by law. Contacts in support of the Down Syndrome Discrimination by Abortion Prohibition Act (S.2754/ H.R.4903 ) to prohibit abortions on the basis that the unborn child has or may have Down syndrome. Contacts in support of the Support And Value Expectant (SAVE) Moms and Babies Act of 2019 (S.3072 /H.R. 4399) to prevent labeling changes for already approved abortion drugs; prevents providers from dispensing these abortion drugs remotely, by mail, or via telemedicine; and prevent the Food and Drug Administration (FDA) from approving new chemical abortion drugs. Contacts regarding the Parental Accessibility Rights for Emergency and Negligent Treatment Act (S.3138) to require any healthcare facility that receives Medicaid or CHIP funds to make public their policies related to the provision, withdrawal, or denial of lifesustaining procedures, nutrition, or medication, policies related to parental consent of these services, and policies related to the required notification of parents and parental consent for a do-not-resuscitate order. Contacts in support of the Teleabortion Prevention Act of 2019 (H.R.4935) to prohibit abortionists from performing chemical abortions without being physically present. Contacts regarding the Parental Right to Know Act (S.3137) to require any healthcare facility that receives Medicaid or CHIP funds to include the information on parental access to medical records of minors under the age of 18 on their website and in print, upon request of the patient or parent. Contacts explaining nonsupport for the Life at Conception Act (S.159/H.R. 616) and the Santity of Human Life Act (H.R. 305) based on lack of clarity and erroneous legal premises. Contacts in support of the Equal Right to Life Act (H.R.4442) to prohibit the prenatal genetic testing or abortion of an unborn child on the basis of the childs presumed sexual orientation. Contacts regarding the Patients First Act of 2019 (S.2308 /H.R.64) to direct HHS to prioritize stem cell research that has the best chance of producing near-term benefits in treatments for patients, without the creation, destruction, or risk of injury to human embryos. Contacts in support of enforcement of numerous federal statues as they relate to the conscience protection rights of those not willing to participate in, refer, or pay for abortion.

H.R. 4399: Support and Value Moms and Babies Act; H.R. 3580/S. 2585: Ensuring Accurate & Complete Abortion Data Reporting Act

Client expense: $200,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

H.R. 4399: Support and Value Moms and Babies Act; H.R. 3580/S. 2585: Ensuring Accurate & Complete Abortion Data Reporting Act; Patients First Act; H.R. 2740: Labor Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020; H.R. 2500/S. 1790: National Defense Authorization Act for Fiscal Year 2020; H.R. 962/S. 130/Discharge Petition H.Res. 102: Born-Alive Abortion Survivors Protection Act, and Discharge Petition; Affordable Care Act enforcement, Abortion separate payments; H.R. 437: Safe Responsible Ethical Scientific Endeavors Assuring Research for Compassionate Healthcare Act (Safe RESEARCH Act); Enforcement of FDA Safety Requirements - abortion drugs; H.R. 3877: Bipartisan Budget Act of 2019; Nondiscrimination in Health and Health Education Programs or Activities

Client expense: $200,000 · Firm income: Not reported

Issues Surrounding Criminal Justice Reform Issues related to the First Step Act Implementation, CJS Appropriations (S. 2585) Issues related to H.R. 1076, S. 387 (Fair Chance Act) and the National Defense Authorization Act (NDAA) S 1074- Pell Grants for Incarcerated individuals

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE